ArticleJournal of biomedical nanotechnology2016

First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development.

Oliver Jonas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.